Parkinson's disease. The possible relationship of laterality to dementia and neurochemical findings.

No abstract is available for this paper.

• Publication year

  1984

• Venue

  Archives of Neurology

• Publication date

  1984-09-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1001/ARCHNEUR.1984.04050200041016PMID 6477229
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• On the origin of homovanillic acid (HVA) in the cerebrospinal fluid

  2005cited by this paper
• Basal forebrain neurons in the dementia of Parkinson disease

  1983cited by this paper
• Relationship of motor symptoms to intellectual deficits in Parkinson disease

  1982cited by this paper
• Sexually dimorphic cerebral asymmetries in 2-deoxy-D-glucose uptake during postnatal development of the rat: correlations with age and relative brain activity.

  1982cited by this paper
• Gradients of monoamine metabolites and cortisol in cerebrospinal fluid of psychiatric patients and healthy controls.

  1982cited by this paper
• Liquid-chromatographic identification of acetaminophen in cerebrospinal fluid with use of electrochemical detection.

  1982cited by this paper
• Lateral asymmetry of neurotransmitters in human brain

  1982cited by this paper
• Depression, intellectual impairment, and Parkinson disease.

  1982cited by this paper
• Depression, intellectual impairment, and Parkinson disease

  1981cited by this paper
• A cortical network for directed attention and unilateral neglect

  1981cited by this paper
• Asymmetrical cognitive deterioration in demented and Parkinson patients.

  1981cited by this paper
• Is the mesocortical dopaminergic system involved in Parkinson disease?

  1980cited by this paper
• Rapid liquid-chromatographic measurement of 3-methoxy-4-hydroxyphenylglycol and other monoamine metabolites in human cerebrospinal fluid.

  1980cited by this paper
• No Evidence for Lateral Asymmetry of Neurotransmitters in Post‐Mortem Human Brain

  1980cited by this paper
• Hemispheric asymmetry of norepinephrine distribution in rat thalamus.

  1980cited by this paper
• The differential effect of right versus left hemispheric cerebral infarction on catecholamines and behavior in the rat.

  1980cited by this paper
• Parkinson disease, dementia, and alzheimer disease: Clinicopathological correlations

  1980cited by this paper
• Differential behavioral and biochemical effects of right and left hemispheric cerebral infarction in the rat.

  1979cited by this paper
• Interactions Between Acetylcholine and Dopamine in the Basal Ganglia

  1979cited by this paper
• Dementia in Parkinson disease

  1979cited by this paper
• Multiple and interrelated functional asymmetries in rat brain.

  1979cited by this paper
• Dementia in Parkinson disease

  1979cited by this paper
• Tactual and auditory vigilance in split-brain man.

  1979cited by this paper
• Right-left asymmetrics in the brain.

  1978cited by this paper
• On the possible role of neocortex and its limbic connections in the process of attention and schizophrenia: clinical cases of inattention in man and experimental anatomy in monkey.

  1978cited by this paper
• Monoaminergic Systems in the Human Limbic Brain

  1978cited by this paper
• CSF studies on the relationship between dopamine and 5-hydroxytryptamine in Parkinsonism and other movement disorders.

  1977cited by this paper
• Diagnostic evaluation and treatment in dementia.

  1977cited by this paper
• Lateralization in the nervous system

  1977cited by this paper
• Depletion of attentional capacity after total commissurotomy in man.

  1976cited by this paper
• Dopamine correlates of neurological and psychological status in untreated Parkinsonism1

  1976cited by this paper
• Is acetylcholinesterase secreted from central neurons into the cerebral fluid?

  1976cited by this paper
• DEMENTIA IN PARKINSON'S DISEASE

  1976cited by this paper
• Is acetylcholinesterase secreted from central neurons into the cerebrospinal fluid

  1976cited by this paper
• Concentration gradients of monoamine metabolites in human cerebrospinal fluid.

  1975cited by this paper
• “Mini-mental state”: A practical method for grading the cognitive state of patients for the clinician

  1975cited by this paper
• Cerebral blood flow in dementia.

  1975cited by this paper
• Parkinson's disease and amine metabolites in cerebrospinal fluid: implications for L-Dopa therapy.

  1974cited by this paper
• Parkinson's disease: a clinical review.

  1974cited by this paper
• Unilateral spatial neglect and impairments of spatial analysis and visual perception.

  1974cited by this paper
• Some psychological factors in Parkinsonism

  1974cited by this paper
• Does levodopa alter depression and psychopathology in Parkinsonism patients?1

  1973cited by this paper
• Brain dopamine and the syndromes of Parkinson and Huntington. Clinical, morphological and neurochemical correlations.

  1973cited by this paper
• The Assessment of Aphasia and Related Disorders

  1973cited by this paper
• Amine metabolites in the cerebrospinal fluid in Parkinson's disease and the response to levodopa.

  1973cited by this paper
• Intellectual impairment in Parkinson's syndrome.

  1972cited by this paper
• Acid monoamine metabolites in the cerebrospinal fluid of patients with Parkinson's disease

  1972cited by this paper
• INTELLECTUAL FUNCTIONING OF PERSONS WITH IDIOPATHIC PARKINSONISM

  1972cited by this paper
• Parkinsonism: alterations in spatial orientation as determined by a route-walking test.

  1972cited by this paper
• Qualitative analysis of unilateral spatial neglect in relation to laterality of cerebral lesions

  1972cited by this paper
• Cerebral dominance in relation to tracking and tapping performance in patients with parkinsonism

  1972cited by this paper
• Cerebrospinal fluid levels of 3-methoxy-4-hydroxyphenylethylene glycol in Parkinsonism before and after treatment with L-dopa.

  1971cited by this paper
• The Minor Cerebral Hemisphere

  1971cited by this paper
• Cerebrospinal fluid levels of 3‐methoxy4hydroxyphenylethylene glycol in Parkinsonism before and after treatment with L‐DOPA 1

  1971cited by this paper
• Hemispheric contribution to exploration of space through the visual and tactile modality.

  1970cited by this paper
• Cerebrospinal fluid monoamine metabolites and peripheral decarboxylase inhibitors in parkinsonism

  1970cited by this paper
• Cerebral metabolites in cerebrospinal fluid as a biochemical approach to the brain.

  1970cited by this paper
• Depressive symptoms in Parkinson patients referred for thalamotomy.

  1967cited by this paper
• The prevalence, natural history and dementia of Parkinson's disease.

  1966cited by this paper
• On the origin of homovanillic acid in the cerebrospinal fluid

  1966cited by this paper
• Mapping out of catecholamine and 5-hydroxytryptamine neurons innervating the telencephalon and diencephalon.

  1965cited by this paper
• COGNITIVE AND PERCEPTUAL PERFORMANCE IN PARKINSONISM AS A FUNCTION OF AGE AND NEUROLOGICAL IMPAIRMENT

  1964cited by this paper
• THE PATTERN OF INTELLECTUAL FUNCTIONING IN PARKINSON PATIENTS.

  1963cited by this paper
• Cognitive function in Parkinson's disease.

  1962cited by this paper
• Cognitive function in Parkinson's disease.

  1962cited by this paper
• A new and rapid colorimetric determination of acetylcholinesterase activity.

  1961cited by this paper
• An inventory for measuring depression.

  1961cited by this paper
• SOMATO‐PSYCHOLOGIC STUDIES IN PARKINSON'S DISEASE I. An Investigation into the Relationship of Certain Disease Factors to Psychological Functions

  1959cited by this paper
• Akinesia in Parkinson's disease

  1959cited by this paper
• A Standardized Memory Scale for Clinical Use

  1945cited by this paper
• VISUAL DISORIENTATION WITH SPECIAL REFERENCE TO LESIONS OF THE RIGHT CEREBRAL HEMISPHERE

  1941cited by this paper

• Impact of motor symptom asymmetry on non-motor outcomes in Parkinson’s disease: a systematic review

  2025cites this paper
• Diagnosing Parkinson’s Disease: its evolution to future

  2022cites this paper
• Lateralisation in Parkinson disease

  2018cites this paper
• Possible selves in patients with right- versus left-onset Parkinson’s disease

  2017cites this paper
• Marked brain asymmetry with intact cognitive functioning in idiopathic Parkinson’s disease: a longitudinal analysis

  2017cites this paper
• Depression in Parkinsonism

  2016cites this paper
• Global attentional neglect of segmented lines in Parkinson’s disease

  2015cites this paper
• Novelty Seeking in Patients with Right- Versus Left-Onset Parkinson Disease

  2015cites this paper
• Investigating the effects of motor symptoms on the development and assessment of non-motor symptoms inidiopathic Parkinson's disease

  2014cites this paper
• Cognitive Differences Between Patients with Left-sided and Right-sided Parkinson’s Disease. A Review

  2011influential citation
• Linguistic correlates of asymmetric motor symptom severity in Parkinson's Disease.

  2010influential citation
• Visual–spatial disembedding in Parkinson's disease

  2010cites this paper
• Neuropsychological performance after unilateral subthalamic deep brain stimulation in Parkinson's disease

  2010cites this paper
• Laterality of Motor Symptom Onset, Disease Progression, and Cognition in Parkinson's Disease

  2010cites this paper
• Neurochemical biomarkers in the differential diagnosis of movement disorders

  2009cites this paper
• Motor asymmetry and substantia nigra volume are related to spatial delayed response performance in Parkinson disease.

  2008cites this paper
• Side and type of motor symptom influence cognition in Parkinson's disease

  2006cites this paper
• Prognostic implications of the motor symptoms of Parkinson's disease with respect to clinical, computertomographic and psychometric parameters

  2005cites this paper
• Heterogeneity of Parkinson’s disease in the early clinical stages using a data driven approach

  2005cites this paper
• Depression in Parkinson's disease: study of 60 cases.

  2005cites this paper
• Lateralisation of striatal function: evidence from 18F-dopa PET in Parkinson’s disease

  2005cites this paper
• Parkinson disease

  2005cites this paper
• Role of Visuospatial Cognition Assessment in the Diagnosis and Research of Atypical Parkinsonian Disorders

  2005cites this paper
• Is there a specific visuospatial impairment in Parkinsonians ?

  2004cites this paper
• Cognitive Dysfunction in Parkinson’s Disease: The Role of Frontostriatal Circuitry

  2004cites this paper
• SimultaneousDeterminationof Four Monoamine Metabolitesand Serotoninin Cerebrospinal Fluidby “ High-Performance ” LiquidChromatographywith ElectrochemicalDetection ; Application for Patientswith Alzheimer ’ sDisease

  2004cites this paper
• Spatial behaviour is driven by proximal cues even in mildly impaired Parkinson's disease.

  2002cites this paper
• Cognition and emotion in different stages and subtypes of Parkinson’s disease

  2000cites this paper
• Recognition memory impairment in Parkinson's disease: power and meta-analyses.

  2000cites this paper
• Parkinson's disease and neuropsychological assessment.

  1999cites this paper
• A neuropsychological comparison of demented and nondemented patients with Parkinson's disease.

  1999cites this paper
• A data‐driven approach to the study of heterogeneity in idiopathic Parkinson's disease: identification of three distinct subtypes

  1999cites this paper
• Cognitive and affective functioning in Parkinson's disease patients with lateralized motor signs.

  1998cites this paper
• Reversal of cognitive impairment in an elderly parkinsonian patient by transcranial application of picotesla electromagnetic fields.

  1997cites this paper
• The long-term impact of treatment with electromagnetic fields on visual memory in Parkinson's disease.

  1996cites this paper
• Improvement in short-term visual memory by weak electromagnetic fields in Parkinson's disease.

  1995cites this paper
• Weak electromagnetic fields reverse visuospatial hemi-inattention in Parkinson's disease.

  1995cites this paper
• Neuropsychological characteristics of parkinsonian patients with lateralized motor impairment

  1995cites this paper
• Reversal of visuospatial deficit on the Clock Drawing Test in Parkinson's disease by treatment with weak electromagnetic fields.

  1995cites this paper
• Improvement of body image perception in Parkinson's disease by treatment with weak electromagnetic fields.

  1995cites this paper
• [Depression in Parkinson disease. A literature review].

  1994cites this paper
• Reversal of a visuoconstructional deficit in Parkinson's disease by application of external magnetic fields: a report of five cases.

  1994cites this paper
• Cognitive slowing in Parkinson's and Alzheimer's patients

  1994cites this paper
• Alzheimer's disease: improvement of visual memory and visuoconstructive performance by treatment with picotesla range magnetic fields.

  1994cites this paper
• Depression beim Parkinson-Syndrom

  1994cites this paper
• [Depression in Parkinson disease. Clinical and etiopathogenic aspects].

  1994cites this paper
• Influence of Brain and Behavioral Lateralization in Brain Monoaminergic, Neuroendocrine, and Immune Stress Responses

  1994cites this paper
• Side of onset of motor symptoms influences cognition in Parkinson's disease

  1993cites this paper
• The effects of picoTesla range magnetic fields on perceptual organization and visual memory in parkinsonism.

  1993cites this paper
• Brain lateralization and immunomodulation.

  1993cites this paper
• Rapid improvement of visuoperceptive functions by picoTesla range magnetic fields in patients with Parkinson's disease.

  1993cites this paper
• Cerebral Laterality as a Determinant of Behavioral Function and Dysfunction

  1992cites this paper
• Neuropsychological and Glucose Metabolic Profiles in Asymmetric Parkinson’s Disease

  1992cites this paper
• Asymmetrical cognitive differences associated with hemiparkinsonism.

  1992cites this paper
• Bilateral olfactory dysfunction in early stage treated and untreated idiopathic Parkinson's disease.

  1992cites this paper
• Asymmetrical brain modulation of the immune response.

  1992cites this paper
• Ricinus communis agglutinin I reacting and non-reacting butyrylcholinesterase in human cerebrospinal fluid.

  1992cites this paper
• Depression and Parkinson's disease: a review.

  1992cites this paper
• Brain and cerebrospinal fluid cholinesterases in Alzheimer's disease, Parkinson's disease and aging. A critical review of clinical and experimental studies

  1992cites this paper
• Neurochemical markers in the cerebrospinal fluid of patients with Alzheimer's disease, Parkinson's disease and amyotrophic lateral sclerosis and normal controls

  1992cites this paper
• Magnetic fields in the therapy of parkinsonism.

  1992cites this paper
• The relationship of tardive dyskinesia to positive schizophrenia.

  1991cites this paper
• Cognition and cerebral blood flow in lateralised parkinsonism: lack of functional lateral asymmetries.

  1991cites this paper
• Clinical comparison of dementia in Parkinson's and Alzheimer's disease.

  1991cites this paper
• Neurobehavioral functioning in Parkinson's disease: The role of basal ganglia-thalamocortical circuit loops in predicting performance.

  1991cites this paper
• Development of an "early" detection battery for dementia of the Alzheimer type.

  1991cites this paper
• The relationship of memory and cognition in Parkinson's disease to lateralisation of motor symptoms.

  1990cites this paper
• Carotid gustatory syndrome in a patient with Holmes-Adie syndrome.

  1990cites this paper
• Neuropsychological aspects of Parkinson's disease

  1990cites this paper
• Cognition and laterality in untreated hemiparkinsonism

  1989cites this paper
• Brain Imaging and Neuropsychological Identification of Dementia of the Alzheimer’s Type

  1989cites this paper
• Neuropsychological Function and Brain Imaging

  1989cites this paper
• Major depression in Parkinson's disease and the mood response to intravenous methylphenidate: possible role of the "hedonic" dopamine synapse.

  1989cites this paper
• Neuropsychological similarities in lateralized parkinsonism.

  1989cites this paper
• Alterations in catecholamine neurons of the locus coeruleus in senile dementia of the Alzheimer type and in Parkinson's disease with and without dementia and depression

  1989cites this paper
• Neuropsychological functioning in hemiparkinsonism.

  1989cites this paper
• The dementias of Parkinson's disease: prevalence, characteristics, neurobiology, and comparison with dementia of the Alzheimer type.

  1988cites this paper
• Parkinson's disease and depression: psychometric properties of the Beck Depression Inventory.

  1988cites this paper
• Intellectual Impairment in Parkinson's Disease: Clinical, Pathologic, and Biochemical Correlates

  1988cites this paper
• Simultaneous determination of four monoamine metabolites and serotonin in cerebrospinal fluid by "high-performance" liquid chromatography with electrochemical detection; application for patients with Alzheimer's disease.

  1988cites this paper
• Dementia in Parkinson’s Disease

  1988cites this paper
• Cerebral neocortex modulation of immune functions.

  1988cites this paper
• Neuropsychological and Computed Tomographic Identification in Dementia

  1988cites this paper
• Simultaneous Determination of FourMonoamine Metabolites andSerotonin in Cerebrospinal Fluidby "High-Performance"Chromatography withElectrochemical Detection; Application forPatientswithAlzheimer's Disease

  1988cites this paper
• Dementia: The Clinical Perspective

  1988cites this paper
• Existe la demencia subcortical

  1988cites this paper
• Neuropsychological performance in lateralized parkinsonism.

  1988cites this paper
• Molecular Forms of Acetylcholinesterase and Butyrylcholinesterase in Human Plasma and Cerebrospinal Fluid

  1987cites this paper
• Acetyl- and butyrylcholinesterase activity in the cerebrospinal fluid of patients with Parkinson's disease.

  1987cites this paper
• Neuropsychological disturbances in hemiparkinson's disease

  1987cites this paper
• Laterality and neurochemical findings in Parkinson's disease.

  1986cites this paper
• Frontal lobe dysfunction in Parkinson's disease. The cortical focus of neostriatal outflow.

  1986cites this paper
• Dementia in Movement Disorders

  1986cites this paper
• Different patterns of CSF neurotransmitter metabolism in patients with left or right hemispheric stroke

  1986cites this paper
• CSF cyclic nucleotides and somatostatin in Parkinson's disease

  1986cites this paper
• Is there a specific visuo-spatial impairment in Parkinsonians?

  1986cites this paper
• Cerebrospinal fluid levels of angiotensin-converting enzyme, acetylcholinesterase, and dopamine metabolites in dementia associated with Alzheimer's disease and Parkinson's disease: a correlative study.

  1986cites this paper
• Subcortical Dementia Neuropsychology, Neuropsychiatry, and Pathophysiology

  1986cites this paper
• The concept of subcortical and cortical dementia: Another look

  1986cites this paper
• Cognitive performance in early Parkinson's disease

  1986cites this paper